Novo Nordisk AS
A3EU6F
DK0062498333 //
Quelle: CPH Equities: 18:18:49
292,40 DKK
Kurs
Kurs
-0,78%
Diff. Vortag in %
Diff. Vortag in %
224,25 DKK
52 Wochen Tief
52 Wochen Tief
409,95 DKK
52 Wochen Hoch
52 Wochen Hoch
- Neutral
- Seit dem 07.07.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 11.08.2026 0 Monate | 11.08.2026 | 0 Monate | 292,40 305 | 292,40 | 305 | 4,309166 | BERENBERG | ||
| Novo Nordisk AS | 07.08.2026 0 Monate | 07.08.2026 | 0 Monate | 292,40 | 292,40 | -- | DZ BANK | |||
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 292,40 285 | 292,40 | 285 | 2,53078 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 292,40 290 | 292,40 | 290 | 0,820793 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 292,40 200 | 292,40 | 200 | 31,600547 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 292,40 332 | 292,40 | 332 | 13,543092 | UBS | ||
| Novo Nordisk AS | 05.08.2026 12 Monate | 05.08.2026 | 12 Monate | 292,40 310 | 292,40 | 310 | 6,019152 | BARCLAYS | ||
| Novo Nordisk AS | 04.08.2026 12 Monate | 04.08.2026 | 12 Monate | 292,40 285 | 292,40 | 285 | 2,53078 | JEFFERIES | ||
| Novo Nordisk AS | 04.08.2026 0 Monate | 04.08.2026 | 0 Monate | 292,40 332 | 292,40 | 332 | 13,543092 | UBS | ||
| Novo Nordisk AS | 31.07.2026 0 Monate | 31.07.2026 | 0 Monate | 292,40 250 | 292,40 | 250 | 14,500684 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 292,40 290 | 292,40 | 290 | 0,820793 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 10.07.2026 0 Monate | 10.07.2026 | 0 Monate | 292,40 332 | 292,40 | 332 | 13,543092 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 29.06.2026 12 Monate | 29.06.2026 | 12 Monate | 292,40 285 | 292,40 | 285 | 2,53078 | JEFFERIES | ||
| Novo Nordisk AS | 28.06.2026 0 Monate | 28.06.2026 | 0 Monate | 292,40 250 | 292,40 | 250 | 14,500684 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 292,40 290 | 292,40 | 290 | 0,820793 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.06.2026 0 Monate | 16.06.2026 | 0 Monate | 292,40 325 | 292,40 | 325 | 11,149111 | BERENBERG | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 292,40 290 | 292,40 | 290 | 0,820793 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 292,40 250 | 292,40 | 250 | 14,500684 | JPMORGAN | ||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 292,40 250 | 292,40 | 250 | 14,500684 | JPMORGAN | ||
| Novo Nordisk AS | 03.06.2026 12 Monate | 03.06.2026 | 12 Monate | 292,40 305 | 292,40 | 305 | 4,309166 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 29.05.2026 0 Monate | 29.05.2026 | 0 Monate | 292,40 270 | 292,40 | 270 | 7,660739 | JEFFERIES | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 292,40 290 | 292,40 | 290 | 0,820793 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 292,40 290 | 292,40 | 290 | 0,820793 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 18.05.2026 0 Monate | 18.05.2026 | 0 Monate | 292,40 300 | 292,40 | 300 | 2,599179 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12.05.2026 12 Monate | 12.05.2026 | 12 Monate | 292,40 270 | 292,40 | 270 | 7,660739 | JEFFERIES | ||
| Novo Nordisk AS | 11.05.2026 12 Monate | 11.05.2026 | 12 Monate | 292,40 175 | 292,40 | 175 | 40,150479 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 292,40 290 | 292,40 | 290 | 0,820793 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 292,40 290 | 292,40 | 290 | 0,820793 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 292,40 | 292,40 | -- | DZ BANK | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 292,40 300 | 292,40 | 300 | 2,599179 | BARCLAYS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 292,40 332 | 292,40 | 332 | 13,543092 | UBS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 292,40 250 | 292,40 | 250 | 14,500684 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 12 Monate | 06.05.2026 | 12 Monate | 292,40 263 | 292,40 | 263 | 10,05472 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 292,40 250 | 292,40 | 250 | 14,500684 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 292,40 175 | 292,40 | 175 | 40,150479 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 292,40 300 | 292,40 | 300 | 2,599179 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 29.04.2026 12 Monate | 29.04.2026 | 12 Monate | 292,40 250 | 292,40 | 250 | 14,500684 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 292,40 275 | 292,40 | 275 | 5,950752 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 292,40 270 | 292,40 | 270 | 7,660739 | JEFFERIES | ||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 292,40 250 | 292,40 | 250 | 14,500684 | JPMORGAN | ||
| Novo Nordisk AS | 15.04.2026 12 Monate | 15.04.2026 | 12 Monate | 292,40 270 | 292,40 | 270 | 7,660739 | JEFFERIES | ||
| Novo Nordisk AS | 09.04.2026 0 Monate | 09.04.2026 | 0 Monate | 292,40 332 | 292,40 | 332 | 13,543092 | UBS | ||
| Novo Nordisk AS | 01.04.2026 0 Monate | 01.04.2026 | 0 Monate | 292,40 270 | 292,40 | 270 | 7,660739 | BARCLAYS | ||
| Novo Nordisk AS | 31.03.2026 12 Monate | 31.03.2026 | 12 Monate | 292,40 263 | 292,40 | 263 | 10,05472 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 30.03.2026 0 Monate | 30.03.2026 | 0 Monate | 292,40 270 | 292,40 | 270 | 7,660739 | BARCLAYS | ||
| Novo Nordisk AS | 29.03.2026 0 Monate | 29.03.2026 | 0 Monate | 292,40 250 | 292,40 | 250 | 14,500684 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 292,40 275 | 292,40 | 275 | 5,950752 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.03.2026 0 Monate | 26.03.2026 | 0 Monate | 292,40 270 | 292,40 | 270 | 7,660739 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 25.03.2026 0 Monate | 25.03.2026 | 0 Monate | 292,40 250 | 292,40 | 250 | 14,500684 | JPMORGAN | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 292,40 270 | 292,40 | 270 | 7,660739 | JEFFERIES | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 292,40 270 | 292,40 | 270 | 7,660739 | BARCLAYS | ||
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 292,40 300 | 292,40 | 300 | 2,599179 | BERENBERG | ||
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 292,40 250 | 292,40 | 250 | 14,500684 | JPMORGAN | ||
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 292,40 270 | 292,40 | 270 | 7,660739 | BARCLAYS | ||
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 292,40 260 | 292,40 | 260 | 11,080711 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 292,40 270 | 292,40 | 270 | 7,660739 | BARCLAYS | ||
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 292,40 270 | 292,40 | 270 | 7,660739 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 292,40 400 | 292,40 | 400 | 36,798906 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 292,40 250 | 292,40 | 250 | 14,500684 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 292,40 400 | 292,40 | 400 | 36,798906 | GOLDMAN SACHS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 292,40 332 | 292,40 | 332 | 13,543092 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 292,40 340 | 292,40 | 340 | 16,27907 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 292,40 275 | 292,40 | 275 | 5,950752 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 292,40 350 | 292,40 | 350 | 19,699042 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 292,40 340 | 292,40 | 340 | 16,27907 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 292,40 275 | 292,40 | 275 | 5,950752 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 292,40 250 | 292,40 | 250 | 14,500684 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 292,40 270 | 292,40 | 270 | 7,660739 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 292,40 340 | 292,40 | 340 | 16,27907 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 292,40 340 | 292,40 | 340 | 16,27907 | BARCLAYS | ||
| Novo Nordisk AS | 17.02.2026 0 Monate | 17.02.2026 | 0 Monate | 292,40 340 | 292,40 | 340 | 16,27907 | BARCLAYS | ||
| Novo Nordisk AS | 12.02.2026 0 Monate | 12.02.2026 | 0 Monate | 292,40 340 | 292,40 | 340 | 16,27907 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12 Monate | 12 Monate | 292,40 400 | 292,40 | 400 | 36,798906 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 292,40 275 | 292,40 | 275 | 5,950752 | JEFFERIES | ||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 292,40 360 | 292,40 | 360 | 23,119015 | BERENBERG | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 292,40 360 | 292,40 | 360 | 23,119015 | BARCLAYS | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 292,40 360 | 292,40 | 360 | 23,119015 | BARCLAYS | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 292,40 350 | 292,40 | 350 | 19,699042 | JPMORGAN | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 292,40 332 | 292,40 | 332 | 13,543092 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 292,40 475 | 292,40 | 475 | 62,4487 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 292,40 332 | 292,40 | 332 | 13,543092 | UBS | ||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 292,40 350 | 292,40 | 350 | 19,699042 | JPMORGAN | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 292,40 270 | 292,40 | 270 | 7,660739 | JEFFERIES | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 292,40 350 | 292,40 | 350 | 19,699042 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 292,40 350 | 292,40 | 350 | 19,699042 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 292,40 360 | 292,40 | 360 | 23,119015 | BARCLAYS | ||
| Novo Nordisk AS | 01.02.2026 0 Monate | 01.02.2026 | 0 Monate | 292,40 390 | 292,40 | 390 | 33,378933 | UBS | ||
| Novo Nordisk AS | 29.01.2026 0 Monate | 29.01.2026 | 0 Monate | 292,40 350 | 292,40 | 350 | 19,699042 | JPMORGAN | ||
| Novo Nordisk AS | 23.01.2026 12 Monate | 23.01.2026 | 12 Monate | 292,40 270 | 292,40 | 270 | 7,660739 | JEFFERIES | ||
| Novo Nordisk AS | 22.01.2026 12 Monate | 22.01.2026 | 12 Monate | 292,40 436 | 292,40 | 436 | 49,110807 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 22.01.2026 0 Monate | 22.01.2026 | 0 Monate | 292,40 415 | 292,40 | 415 | 41,928865 | BERENBERG | ||
| Novo Nordisk AS | 21.01.2026 12 Monate | 21.01.2026 | 12 Monate | 292,40 360 | 292,40 | 360 | 23,119015 | BARCLAYS | ||
| Novo Nordisk AS | 20.01.2026 12 Monate | 20.01.2026 | 12 Monate | 292,40 270 | 292,40 | 270 | 7,660739 | JEFFERIES | ||
| Novo Nordisk AS | 20.01.2026 0 Monate | 20.01.2026 | 0 Monate | 292,40 390 | 292,40 | 390 | 33,378933 | UBS | ||
| Novo Nordisk AS | 19.01.2026 0 Monate | 19.01.2026 | 0 Monate | 292,40 390 | 292,40 | 390 | 33,378933 | UBS | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 292,40 360 | 292,40 | 360 | 23,119015 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 15.01.2026 0 Monate | 15.01.2026 | 0 Monate | 292,40 415 | 292,40 | 415 | 41,928865 | BERENBERG | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 292,40 475 | 292,40 | 475 | 62,4487 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 292,40 350 | 292,40 | 350 | 19,699042 | JPMORGAN | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 292,40 390 | 292,40 | 390 | 33,378933 | UBS |
News
Aktuell
| Datum | Terminart Information | Information |
|---|---|---|
| 04.11.2026 | Bericht zum 3. Quartal Novo Nordisk A/S: Third quarter 2026 | Novo Nordisk A/S: Third quarter 2026 |
Anlage-Spezial Europäische Aktien
28.05.2026
Novo Nordisk: KI und Amycretin zünden nächste Pipeline-Stufe
KI beschleunigt die Wirkstoffforschung von Novo Nordisk erheblich. Neue Tabletten wie Amycretin sichern dabei die künftige Marktdominanz ab.
DZ BANK Produktauswahl
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Min
Discount in %
Max
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Mini-Futures Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M